Keyphrases
Antiphospholipid Syndrome
100%
Thrombotic
100%
Novel Targeted Therapy
100%
Thrombosis
42%
Treatment Strategy
28%
Antiphospholipid Antibodies
28%
Pathophysiology
14%
Aspirin
14%
Pregnancy Morbidity
14%
Current Treatment
14%
Warfarin
14%
Immunosuppressive Agents
14%
Statins
14%
Antiplatelet Drugs
14%
High Mortality Rate
14%
Clopidogrel
14%
Hydroxychloroquine
14%
Sirolimus
14%
Rituximab
14%
Systemic Autoimmune Diseases
14%
Apixaban
14%
Vitamin K Antagonists
14%
Dabigatran
14%
Rivaroxaban
14%
Non-vitamin K Antagonist Oral Anticoagulants
14%
Eculizumab
14%
Optimal Regimen
14%
Pharmacology, Toxicology and Pharmaceutical Science
Antiphospholipid Syndrome
100%
Thrombosis
57%
Antiphospholipid Antibody
28%
Antivitamin K
28%
Mortality Rate
14%
Autoimmune Disease
14%
Acetylsalicylic Acid
14%
Pathophysiology
14%
Warfarin
14%
Rapamycin
14%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
14%
Anticoagulant Agent
14%
Antiplatelet
14%
Clopidogrel
14%
Hydroxychloroquine
14%
Rituximab
14%
Apixaban
14%
Dabigatran
14%
Rivaroxaban
14%
Eculizumab
14%